• Produktbild: Antibody Methods and Protocols
  • Produktbild: Antibody Methods and Protocols
Band 901

Antibody Methods and Protocols

Fr. 188.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.08.2016

Herausgeber

Gabriele Proetzel + weitere

Verlag

Humana Press

Seitenzahl

325

Maße (L/B/H)

25.4/17.8/1.9 cm

Gewicht

647 g

Auflage

Softcover reprint of the original 1st ed. 2012

Sprache

Englisch

ISBN

978-1-4939-5930-3

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.08.2016

Herausgeber

Verlag

Humana Press

Seitenzahl

325

Maße (L/B/H)

25.4/17.8/1.9 cm

Gewicht

647 g

Auflage

Softcover reprint of the original 1st ed. 2012

Sprache

Englisch

ISBN

978-1-4939-5930-3

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Antibody Methods and Protocols
  • Produktbild: Antibody Methods and Protocols
  • 1. Antigen Presentation for the Generation of Binding Molecules            Hilmar Ebersbach, Gabriele Proetzel, and Chonghui Zhang 2. Recombinant Antibodies and In Vitro Selection Technologies            C. Ronald Geyer, John McCafferty, Stefan Dübel, Andrew R.M. Bradbury, and Sachdev S. Sidhu 3. Phage Display            Konstantin Petropoulos 4. Generation of Human Fab Libraries for Phage Display            Christoph Rader 5. Selection of Human Fab Libraries by Phage Display            Christoph Rader 6. Ribosome Display            George Thom and Maria Groves 7. Hybridoma Technology for the Generation of Monoclonal Antibodies            Chonghui Zhang 8. The Application of Transgenic Mice for Therapeutic Antibody Discovery            E-Chiang Lee and Michael Owen 9. Production of Human or Humanized Antibodies in Mice            Brice Laffleur, Virginie Pascal, Christophe Sirac, and Michel Cogné 10. Immortalization of Human B Cells: Analysis of B Cell Repertoire and Production of Human Monoclonal Antibodies            Elisabetta Traggiai 11. Kinetic Screening in the Antibody Development Process            Michael Schräml and Matthias Biehl 12. Temperature-Dependent Antibody Kinetics as a Tool in Antibody Lead Selection            Michael Schräml and Leopold von Proff 13. Determination of Antibody Glycosylation by Mass Spectrometry            Christiane Jäger, Claudia Ferrara, Pablo Umaña, Anne Zeck, Jörg Thomas Regula, and Hans Koll 14. Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Konstantin Petropoulos 4. Generation of Human Fab Libraries for Phage Display            Christoph Rader 5. Selection of Human Fab Libraries by Phage Display            Christoph Rader 6. Ribosome Display            George Thom and Maria Groves 7. Hybridoma Technology for the Generation of Monoclonal Antibodies            Chonghui Zhang 8. The Application of Transgenic Mice for Therapeutic Antibody Discovery            E-Chiang Lee and Michael Owen 9. Production of Human or Humanized Antibodies in Mice            Brice Laffleur, Virginie Pascal, Christophe Sirac, and Michel Cogné 10. Immortalization of Human B Cells: Analysis of B Cell Repertoire and Production of Human Monoclonal Antibodies            Elisabetta Traggiai 11. Kinetic Screening in the Antibody Development Process            Michael Schräml and Matthias Biehl 12. Temperature-Dependent Antibody Kinetics as a Tool in Antibody Lead Selection            Michael Schräml and Leopold von Proff 13. Determination of Antibody Glycosylation by Mass Spectrometry            Christiane Jäger, Claudia Ferrara, Pablo Umaña, Anne Zeck, Jörg Thomas Regula, and Hans Koll 14. Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Brice Laffleur, Virginie Pascal, Christophe Sirac, and Michel Cogné 10. Immortalization of Human B Cells: Analysis of B Cell Repertoire and Production of Human Monoclonal Antibodies            Elisabetta Traggiai 11. Kinetic Screening in the Antibody Development Process            Michael Schräml and Matthias Biehl 12. Temperature-Dependent Antibody Kinetics as a Tool in Antibody Lead Selection            Michael Schräml and Leopold von Proff 13. Determination of Antibody Glycosylation by Mass Spectrometry            Christiane Jäger, Claudia Ferrara, Pablo Umaña, Anne Zeck, Jörg Thomas Regula, and Hans Koll 14. Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Elisabetta Traggiai 11. Kinetic Screening in the Antibody Development Process            Michael Schräml and Matthias Biehl 12. Temperature-Dependent Antibody Kinetics as a Tool in Antibody Lead Selection            Michael Schräml and Leopold von Proff 13. Determination of Antibody Glycosylation by Mass Spectrometry            Christiane Jäger, Claudia Ferrara, Pablo Umaña, Anne Zeck, Jörg Thomas Regula, and Hans Koll 14. Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Michael Schräml and Matthias Biehl 12. Temperature-Dependent Antibody Kinetics as a Tool in Antibody Lead Selection            Michael Schräml and Leopold von Proff 13. Determination of Antibody Glycosylation by Mass Spectrometry            Christiane Jäger, Claudia Ferrara, Pablo Umaña, Anne Zeck, Jörg Thomas Regula, and Hans Koll 14. Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Michael Schräml and Leopold von Proff 13. Determination of Antibody Glycosylation by Mass Spectrometry            Christiane Jäger, Claudia Ferrara, Pablo Umaña, Anne Zeck, Jörg Thomas Regula, and Hans Koll 14. Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné 13. Determination of Antibody Glycosylation by Mass Spectrometry            Christiane Jäger, Claudia Ferrara, Pablo Umaña, Anne Zeck, Jörg Thomas Regula, and Hans Koll 14. Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Christiane Jäger, Claudia Ferrara, Pablo Umaña, Anne Zeck, Jörg Thomas Regula, and Hans Koll 14. Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Jiahui Yang and Christoph Rader 15. PEGylation of Antibody Fragments for Half-Life Extension            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Simona Jevševar, Mateja Kusterle, and Maja Kenig 16. Bispecific Antibody Derivatives Based on Full-Length IgG Formats            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Michael Grote, Alexander K. Haas, Christian Klein, Wolfgang Schaefer, and Ulrich Brinkmann 17. Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Alexander K. Haas, Klaus Mayer, and Ulrich Brinkmann 18. Methods to Engineer and Identify IgG1 Variants with Improved FcRn Binding or Effector Function            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Robert F. Kelley and Y. Gloria Meng 19. Class-Specific Effector Functions of Therapeutic Antibodies            Virginie Pascal, Brice Laffleur, and Michel Cogné            Virginie Pascal, Brice Laffleur, and Michel Cogné